Literature DB >> 8189489

Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

M Tamura1, R G Webster, F A Ennis.   

Abstract

Antibody-dependent enhancement of the uptake of influenza A virus by Fc receptor-bearing cells was analyzed by using virus strains of the three human influenza A virus subtypes, A/PR/8/34 (H1N1), A/Japan/305/57 (H2N2), and A/Port Chalmers/1/73 (H3N2). Immune sera obtained from mice following primary infection with an H1N1, H2N2, or H3N2 subtype virus neutralized only virus of the same subtype; however, immune sera augmented the uptake of virus across subtypes. Immune sera from H1N1-infected mice augmented uptake of the homologous (H1N1) and H2N2 viruses. Antisera to the H2N2 virus augmented the uptake of virus of all subtypes (H1N1, H2N2, or H3N2). Antisera to the H3N2 virus augmented the uptake of the homologous (H3N2) and H2N2 viruses. These results show that subtype cross-reactive, nonneutralizing antibodies augment the uptake of influenza A virus strains of different subtypes. Antibodies to neuraminidase may contribute to the enhanced uptake of viruses of a different subtype, because N2-specific monoclonal antibodies augmented the uptake of both A/Japan/305/57 (H2N2) and A/Port Chalmers/1/73 (H3N2) viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189489      PMCID: PMC236853     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

Review 2.  Structure and diversity of influenza virus neuraminidase.

Authors:  P M Colman; C W Ward
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

3.  Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1.

Authors:  H Ochiai; M Kurokawa; K Hayashi; S Niwayama
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Antibody-dependent enhancement of HIV infection.

Authors: 
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

5.  Enhanced activation of a T cell line specific for acetylcholine receptor (AChR) by using anti-AChR monoclonal antibodies plus receptors.

Authors:  B C Schalke; W E Klinkert; H Wekerle; D S Dwyer
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

6.  Antibodies to HA and NA augment uptake of influenza A viruses into cells via Fc receptor entry.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

7.  Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

8.  Infection enhancement of influenza A H1 subtype viruses in macrophage-like P388D1 cells by cross-reactive antibodies.

Authors:  H Ochiai; M Kurokawa; Y Kuroki; S Niwayama
Journal:  J Med Virol       Date:  1990-04       Impact factor: 2.327

9.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

Authors:  A Takeda; C U Tuazon; F A Ennis
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

10.  Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies.

Authors:  F Manca; D Fenoglio; G Li Pira; A Kunkl; F Celada
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  20 in total

1.  Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.

Authors:  R Anderson; S Wang; C Osiowy; A C Issekutz
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 2.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

3.  Pseudovirions as vehicles for the delivery of siRNA.

Authors:  Paul E Lund; Ryan C Hunt; Michael M Gottesman; Chava Kimchi-Sarfaty
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

4.  Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

Authors:  Jørgen de Jonge; Johanna M Leenhouts; Marijke Holtrop; Pieter Schoen; Peter Scherrer; Pieter R Cullis; Jan Wilschut; Anke Huckriede
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

Review 5.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

6.  Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.

Authors:  Ramil Sapinoro; Ketna Volcy; W W Shanaka I Rodrigo; Jacob J Schlesinger; Stephen Dewhurst
Journal:  Virology       Date:  2008-01-14       Impact factor: 3.616

7.  High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

Authors:  Kelvin K W To; Anna J X Zhang; Ivan F N Hung; Ting Xu; Whitney C T Ip; Rebecca T Y Wong; Joseph C K Ng; Jasper F W Chan; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2012-05-09

8.  Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.

Authors:  Baoying Huang; Wenling Wang; Renqing Li; Xiuping Wang; Tao Jiang; Xiangrong Qi; Yingying Gao; Wenjie Tan; Li Ruan
Journal:  Virol J       Date:  2012-12-29       Impact factor: 4.099

9.  Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.

Authors:  Geert Leroux-Roels; Cathy Maes; Frédéric Clement; Frank van Engelenburg; Marieke van den Dobbelsteen; Michael Adler; Mario Amacker; Lucia Lopalco; Morgane Bomsel; Anick Chalifour; Sylvain Fleury
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection.

Authors:  Thavamalar Balakrishnan; Dennis B Bela-Ong; Ying Xiu Toh; Marie Flamand; Shamala Devi; Mickey B Koh; Martin L Hibberd; Eng Eong Ooi; Jenny G Low; Yee Sin Leo; Feng Gu; Katja Fink
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.